TABLE 4.
Features of IC Compared With Non-IC Subjects in 302 Patients With Crypto at UAB, 1996–2010
| Characteristic | IC N = 263 (%) | Non-IC N = 39 (%) | P Value |
|---|---|---|---|
| Site of involvement | |||
| CNS | 175 (67) | 25 (64) | 0.752 |
| Bloodstream | 95 (36) | 1 (3) | <0.001 |
| Pulmonary | 72 (27) | 16 (41) | 0.067 |
| Clinical presentation | |||
| Headache | 132 (50) | 19 (49) | 0.864 |
| Fever | 99 (38) | 9 (23) | 0.072 |
| Altered mental status | 88 (33) | 7 (18) | 0.053 |
| Visual changes | 34 (13) | 8 (21) | 0.209 |
| Cough | 51 (19) | 9 (23) | 0.607 |
| Dyspnea | 45 (17) | 10 (26) | 0.206 |
| Mean time to diagnosis, days | 34 | 81 | <0.001 |
Abbreviations: IC, immunocompromised: CNS, central nervous system.